{"id":1274181,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-28","captureTimestamp":"2026-03-28T05:28:10.721000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html?wbdisable=false","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1274181","browseUrl":"https://replay.healtharchive.ca/job-8/20260328052810/https://cihr-irsc.gc.ca/e/52735.html?wbdisable=false#ha_snapshot=1274181","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}